Welcome to Starhope Clinical Research -Advancing Liver Health in San Antonio


At Starhope Clinical Research, we specialize in Phase 2 and 3 clinical trials, playing a crucial role in advancing the understanding and treatment of liver disorders. Under Dr. Membreno's expert guidance, our team is committed to excellence in patient care and research.


Our mission is to provide a NEW HOPE in the future by assisting in the development of innovative therapies through clinical research. Our goal is to bring life-changing treatments to patients while contributing to the future of liver healthcare. Join us at Starhope Clinical Research as we work to shape the future of liver disease treatments and improve patient outcomes.



Call to Register

Located in San Antonio, Texas, Starhope Clinical Research is a leading clinical research center focused on groundbreaking studies in liver diseases. Led by Dr. Fernando Membreno, MD, a respected liver transplant hepatologist and gastroenterologist with over 20 years of clinical experience, our center is dedicated to exploring innovative treatments for Metabolic Associated Steatohepatitis (MASH), obesity, compensated and decompensated cirrhosis, hepatoma, and a variety of other liver conditions.


Our mission is to provide a NEW HOPE in the future by assisting in the development of innovative therapies through clinical research. Our goal is to bring life-changing treatments to patients while contributing to the future of liver healthcare. Join us at Starhope Clinical Research as we work to shape the future of liver disease treatments and improve patient outcomes.


Liver Health Research Study:

Get Involved

Help researchers understand Alcoholic Liver Disease and test a once-weekly injection that may reduce liver inflammation.

You may be eligible to participate in this study if you*:


  • Are ages 18-75.                         
  • Have a history of alcohol misuse
  • Do not have cirrhosis or diabetes



*Additional Criteria will be assessed to confirm eligibility


If you qualify, you’ll receive study-related care at no cost and may be eligible for

compensation for your time and travel. By participating, you’ll not only gain access to

expert care but also play a role in advancing Alcoholic Liver Disease research.

For more information, and to connect with a participating clinical trial site:



Check Your Eligibility


Starhope is presently seeking patients diagnosed with MASH Compensated Cirrhosis, actively providing a promising treatment option for individuals who are suffering from the significant challenges of cirrhosis and currently have no available therapies to alleviate their condition. This initiative aims to offer hope and improve the quality of life for those living with this serious liver disease. By participating in this study, patients can potentially access innovative treatments that may lead to better health outcomes.



Starhope Clinical Research

Direct phone line: 210-469-3472

Efax for Research Referrals: 800-355-1653


Call to Register


FAQ

  • Do you have any clinical trials available?

    Yes, we have ongoing clinical trials constantly. For more accurate information, please click the "Trials" button on the bottom of the page.

  • What's your mission?

    Our mission is to provide a NEW HOPE in the future by assisting in the development of innovative therapies through clinical research. Our goal is to bring life-changing treatments to patients while contributing to the future of liver healthcare. Join us at Starhope Clinical Research as we work to shape the future of liver disease treatments and improve patient outcomes.

  • What do you specialize in?

    At Starhope Clinical Research, we specialize in Phase 2 and 3 clinical trials, playing a crucial role in advancing the understanding and treatment of liver disorders. Under Dr. Membreno's expert guidance, our team is committed to excellence in patient care and research. We are also expanding our capabilities to include a Phase 1 unit, specifically designed for liver protocols, to support early-stage clinical studies.